Rifaximin in Patients With Diabetic Gastroparesis

Clinical trial NCT04254549 · TERMINATED

Trial details

NCT number: NCT04254549
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn Disease Diabetic Gastroparesis

Start date: 2019-06-14
Primary completion: 2025-04-08
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.